成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Relugolix
Relugolix
  • Relugolix

Relugolix NEW

Price Get Latest Price
Package 1KG 5KG 25KG
Min. Order: 1KG
Supply Ability: 1 ton
Update Time: 2024-11-01

Product Details

Product Name: Relugolix CAS No.: 737789-87-6
EC-No.: 237-099-7 Min. Order: 1KG
Purity: EP/USP Supply Ability: 1 ton
Release date: 2024/11/01
Appearance: White crystalline solid

Description:

Relugolix is an oral medication that acts as a gonadotropin-releasing hormone (GnRH) receptor antagonist. It is primarily used in the treatment of hormone-sensitive conditions, such as prostate cancer and uterine fibroids.


Key Information and Uses:

Indications:

Prostate Cancer: Relugolix is indicated for the treatment of advanced prostate cancer. It helps to lower testosterone levels, which can slow the growth of cancer cells that depend on testosterone.

Uterine Fibroids: It is also used to treat moderate to severe symptoms associated with uterine fibroids in women of reproductive age, such as heavy menstrual bleeding and pelvic pain.

Mechanism of Action:

Relugolix works by blocking the GnRH receptors in the pituitary gland, leading to a decrease in the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This results in reduced production of sex hormones (testosterone in men and estrogen in women), which is beneficial in managing hormone-sensitive conditions.

Administration:

Relugolix is taken orally, typically once daily. Patients are advised to follow their healthcare provider's instructions regarding dosage and administration.

Side Effects:

Common side effects may include hot flashes, fatigue, weight gain, and changes in blood lipid levels. It may also lead to decreased bone density over time, so monitoring is important.

Clinical Trials:

Relugolix has been evaluated in clinical trials, demonstrating its effectiveness in reducing symptoms and managing hormone levels in patients with prostate cancer and uterine fibroids.

Approval:

The drug has received approval from regulatory authorities, including the U.S. Food and Drug Administration (FDA), for its indicated uses.


Company Profile Introduction

We are experts in providing raw materials, resources, customized manufacturing, and much more. We especially pride ourselves on the partnership in the manufacturing of high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients. Among them, our key client industrial sectors around the globe are: Pharmaceuticals. Cosmetics. Nutritional Supplements. And Special Chemicals.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$31.00/1mg
VIP5Y
TargetMol Chemicals Inc.
2024-10-31
$0.00/10mg
VIP1Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-08-13
$0.10/1KG
VIP5Y
Shaanxi Dideu Medichem Co. Ltd
2024-08-05
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-07-24
$5.00/25kg
Ouhuang Engineering Materials (Hubei) Co., Ltd
2024-04-25
$1.00/1g
VIP4Y
Dorne Chemical Technology co. LTD
2024-03-26
$0.00/1kg
VIP1Y
Shandong Hanjiang Chemical Co., Ltd
2024-01-22
$0.00/1g
VIP1Y
Biopole Pharmatech Co., Ltd.
2024-01-19
$0.00/25KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-08-14
$0.00/1g
VIP2Y
shandong perfect biotechnology co.ltd
2023-08-14
  • Since: 2013-11-01
  • Address: Room 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Road, Gongshu District, Hangzhou, Z
INQUIRY
劉偉
+86-13675893055
info@hyper-chem.com